Mesoblast Limited
MESO · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1,315 | $669 | $655 | $303 |
| - Cash | $161 | $63 | $71 | $60 |
| + Debt | $128 | $119 | $116 | $107 |
| Enterprise Value | $1,282 | $725 | $701 | $350 |
| Revenue | $17 | $6 | $8 | $10 |
| % Growth | 191.4% | -21.3% | -26.5% | – |
| Gross Profit | $12 | -$35 | -$47 | -$53 |
| % Margin | 70.2% | -595.9% | -632.2% | -522.6% |
| EBITDA | -$74 | -$56 | -$59 | -$77 |
| % Margin | -428.3% | -950.1% | -780.6% | -749.9% |
| Net Income | -$102 | -$88 | -$82 | -$91 |
| % Margin | -593.9% | -1,490.3% | -1,091.7% | -894.6% |
| EPS Diluted | -0.84 | -0.89 | -0.98 | -1.3 |
| % Growth | 5.6% | 9.2% | 24.6% | – |
| Operating Cash Flow | -$50 | -$48 | -$63 | -$66 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$51 | -$49 | -$64 | -$66 |